Phys.org·4 min read·hard
Engineered bacterial spores reveal new protein targets for enzymes and vaccines
✦AI Summary
Researchers at Tufts University are engineering bacterial spores to serve as stable carriers for enzymes, drugs, and vaccines. By fusing functional molecules to the spore's protein coat, scientists aim to create products that can withstand extreme environmental conditions without refrigeration.
Why it matters
This technology could revolutionize the distribution of medical and industrial products in resource-limited settings or harsh environments.
edited by Gaby Clark , reviewed by Robert Egan
sciencehealthtechnology
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The article is a scientific report focused on research developments.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in